Back to results
US 2013/0251669 A1Published application
Treatment of diabetes using g-csf and hyperbaric oxygen
AssigneeAdvanced Neuroregenerative Therapies, LLC.
InventorDipnarine MAHARAJ
Life of this patent
Estimating the term…
Abstract
A method of treating endothelial cells comprising: inducing vasodilation in a patient; and administering a composition including a stem cell proliferation agent to the patient.
Claims13
1-20. (canceled)
A method for causing glucose levels to trend lower in a patient having diabetes, both during and after treatment with a combination of vasodilation and stem cell proliferation comprising:
- exposing said patient to an agent and/or a therapy to induce vasodilation;
- exposing said patient to a stem cell proliferation agent;
- and
- further exposing said patient to an agent/or therapy to induce vasodilation;
- wherein said patient's blood glucose level begins trending lower subsequent to initiation of treatment and continues to trend lower after active treatment has ended.
2 more elements
A method for causing glucose levels to trend lower in a patient having diabetes, both during and after stem cell proliferation treatment comprising:
- inducing stem cell proliferation by administering a granulocyte colony stimulating factor, a derivative or isomer thereof for a period of about seven consecutive days, in an amount effective to result in stem cell mobilization;
- providing a waiting period of about eight to fourteen days during which no active treatment is conducted;
- further inducing stem cell proliferation by administering a granulocyte colony stimulating factor, a derivative or isomer thereof for a period of about seven consecutive days, in an amount effective to result in stem cell mobilization;
- further providing a waiting period of about eight to fourteen days during which no active treatment is conducted;
- and
- further inducing stem cell proliferation by administering a granulocyte colony stimulating factor, a derivative or isomer thereof for a period of about seven consecutive days, in an amount effective to result in stem cell mobilization;
- wherein said patient's blood glucose level begins trending lower subsequent to initiation of treatment and continues to trend lower after active treatment has ended.
4 more elements
Dependencies are inferred from the claim text.